Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Upsher-Smith Laboratories, LLC
Home
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
News
Plant C
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
800-654-2299
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
Plant C
News
800-654-2299
Financial Results for the 1st Half of FY 2019
November 15, 2019
Company News
Share:
Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email
Download Press Release
Summary of Financial Results for 1st Half of FY 2019
Upsher-Smith Laboratories Adds Zembrace Symtouch (sumatriptan) Injection to its Access Pathways Platinum Pass Savings Program
Careers
Join Our Team!
We’re hiring
Search Our Jobs
Close
